ACEA goes live with exhaustive, searchable library of NovoCyte publications

ACEA Biosciences goes live with exhaustive library of NovoCyte papers spanning dozens of different applications

With the 2014 release of its NovoCyte flow cytometer ACEA Biosciences delivered a highly innovative instrument at an extremely competitive price point. In the ensuing three years features such as automated fluidics protocols, a highly flexible and upgradable optical platform, autosampling, direct volumetric cell counting, and the industry leading NovoExpress software have enabled the NovoCyte to quickly gain broad market penetrance. These instruments are now being used for diverse applications in hundreds of academic, government, industrial, and CRO laboratories worldwide. Due to NovoCyte’s phenomenal rate of adoption, a steady flow of peer-reviewed research articles employing this instrument are now being published.

As a tool for viewing these real world examples of NovoCyte’s utility for specific applications, today ACEA launched a comprehensive and searchable online library. “This collection of publications, which can be queried based on application, will help prospective and existing NovoCyte users readily find information and protocols,” stated Rene Nunez, ACEA’s Associate Director of Marketing.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.